LONG-TERM FOLLOW-UP RESULTS OF PATIENTS WITH STAGE IC-IV OVARIAN-CANCER TREATED WITH CISPLATIN, EPIRUBICIN AND IFOSFAMIDE CHEMOTHERAPY

  • Authors:
    • T NISHIDA
    • T ODA
    • T SUGIYAMA
    • A KATAOKA
    • K USHIJIMA
    • M YAKUSHIJI
  • View Affiliations

  • Published online on: September 1, 1995     https://doi.org/10.3892/or.2.5.731
  • Pages: 731-736
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Sixty-three patients with stage Ic-IV ovarian cancer received cisplatin, epirubicin and ifosfamide chemotherapy following a staging surgery between 1985 and 1992. The optimal surgery (without macroscopic residual was completed in 44 patients including 12 stage III cases. A 5-year survival of 97.5% was obtained for the optimal cases; whereas that for suboptimal cases was only 24.0%. From the results, the regimen proved to be a promising adjuvant therapy for ovarian cancer after optimal surgery; moreover a need for a drastic amelioration of strategy is emphasized in the treatment of advanced ovarian cancer with extensive metastases.

Related Articles

Journal Cover

September 1995
Volume 2 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
NISHIDA T, ODA T, SUGIYAMA T, KATAOKA A, USHIJIMA K and YAKUSHIJI M: LONG-TERM FOLLOW-UP RESULTS OF PATIENTS WITH STAGE IC-IV OVARIAN-CANCER TREATED WITH CISPLATIN, EPIRUBICIN AND IFOSFAMIDE CHEMOTHERAPY. Oncol Rep 2: 731-736, 1995
APA
NISHIDA, T., ODA, T., SUGIYAMA, T., KATAOKA, A., USHIJIMA, K., & YAKUSHIJI, M. (1995). LONG-TERM FOLLOW-UP RESULTS OF PATIENTS WITH STAGE IC-IV OVARIAN-CANCER TREATED WITH CISPLATIN, EPIRUBICIN AND IFOSFAMIDE CHEMOTHERAPY. Oncology Reports, 2, 731-736. https://doi.org/10.3892/or.2.5.731
MLA
NISHIDA, T., ODA, T., SUGIYAMA, T., KATAOKA, A., USHIJIMA, K., YAKUSHIJI, M."LONG-TERM FOLLOW-UP RESULTS OF PATIENTS WITH STAGE IC-IV OVARIAN-CANCER TREATED WITH CISPLATIN, EPIRUBICIN AND IFOSFAMIDE CHEMOTHERAPY". Oncology Reports 2.5 (1995): 731-736.
Chicago
NISHIDA, T., ODA, T., SUGIYAMA, T., KATAOKA, A., USHIJIMA, K., YAKUSHIJI, M."LONG-TERM FOLLOW-UP RESULTS OF PATIENTS WITH STAGE IC-IV OVARIAN-CANCER TREATED WITH CISPLATIN, EPIRUBICIN AND IFOSFAMIDE CHEMOTHERAPY". Oncology Reports 2, no. 5 (1995): 731-736. https://doi.org/10.3892/or.2.5.731